Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti–tumor necrosis factor α therapy: results from the …

…, S Rifbjerg‐Madsen, T Lorenzen… - Arthritis & …, 2011 - Wiley Online Library
Objective To investigate disease activity, treatment response, and drug survival, and predictors
thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment …

Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working …

…, P Hanova, P Macchioni, TA Kermani, T Lorenzen… - RMD open, 2018 - rmdopen.bmj.com
Objectives To define the elementary ultrasound (US) lesions in giant cell arteritis (GCA) and
to evaluate the reliability of the assessment of US lesions according to these definitions in a …

Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry

…, NS Krogh, H Foged, U Tarp, T Lorenzen… - Annals of the …, 2011 - ard.bmj.com
Objectives To describe drug survival, disease activity and clinical response in patients with
rheumatoid arthritis (RA) treated with abatacept or tocilizumab in routine care, based on …

Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide …

…, AG Rasmussen Loft, R Pelck, T Lorenzen… - …, 2016 - academic.oup.com
Objectives. To investigate the association between tobacco smoking and disease activity,
treatment adherence and treatment responses in patients with AS treated with their first tumour …

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded …

…, M Kapetanovic, F Faustini, R Tuompo, T Lorenzen… - bmj, 2020 - bmj.com
Objective To evaluate and compare benefits and harms of three biological treatments with
different modes of action versus active conventional treatment in patients with early …

Discordance of global assessments by patient and physician is higher in female than in male patients regardless of the physician's sex: data on patients with …

…, B Glintborg, MR Kowalski, T Lorenzen… - The Journal of …, 2015 - jrheum.org
Objective. To assess the frequency of discordance in patient’s (PtGA) and physician’s (PGA)
global assessment, and to investigate whether higher discordance in female patients …

Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

…, R Pelck, A Kincses, H Nordin, T Lorenzen… - Clinical …, 2017 - Taylor & Francis
Objectives In Denmark, patients with rheumatoid arthritis (RA) are registered in the nationwide
clinical DANBIO quality register and the Danish National Patient Registry (DNPR). The …

Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish …

…, R Christensen, H Bliddal, T Lorenzen… - …, 2015 - academic.oup.com
Objectives. To estimate the prevalence of Danish RA patients currently on biologic monotherapy
and compare the effectiveness and drug adherence of biologic therapies applied as …

Assessing vasculitis in giant cell arteritis by ultrasound: results of OMERACT patient-based reliability exercises

…, A Juche, TA Kermani, MJ Koster, T Lorenzen… - The Journal of …, 2018 - jrheum.org
Objective. To test the reliability of Outcome Measures in Rheumatology Clinical Trials (OMERACT)
consensus-based ultrasound definitions for normal and vasculitic temporal and …

Diagnostic accuracy of vascular ultrasound in patients with suspected giant cell arteritis (EUREKA): a prospective, multicentre, non-interventional, cohort study

…, L Terslev, U Fredberg, T Lorenzen… - The Lancet …, 2021 - thelancet.com
Background Temporal artery biopsy is considered the diagnostic gold standard for giant cell
arteritis, despite approximately 39% of patients who are negative for the condition by biopsy …